Medpace Holdings Inc
NASDAQ:MEDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
L E Lundbergforetagen AB (publ)
F:LU3B
|
SE |
|
K
|
Kering SA
SWB:PPX
|
FR |
|
D
|
Dole PLC
F:4CB
|
IE |
|
Omer Decugis & Cie SA
F:0VC
|
FR |
|
S
|
SLB NV
DUS:SCL
|
US |
|
H
|
Halliburton Co
BMV:HAL
|
US |
|
H
|
Halliburton Co
DUS:HAL
|
US |
|
H
|
Halliburton Co
F:HAL
|
US |
|
H
|
Halliburton Co
XMUN:HAL
|
US |
Intrinsic Value
Is MEDP undervalued or overvalued?
See the intrinsic value estimate for Medpace Holdings Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Medpace Does
Medpace Holdings is a contract research company that helps drug and medical device makers run clinical trials. It designs study plans, manages sites and patients, collects trial data, and handles the regulatory and operational work needed to test new treatments. Its customers are mainly biopharma companies, biotech startups, and medical device firms that need outside expertise to get products through development.
- Headquarters
- United States of America US
- Employees
- 6 300
- IPO date
- Aug 11, 2016
Medpace Holdings has a narrow economic moat
Changing providers during an active clinical trial can require transferring study records, shifting site coordination and onboarding a new team, creating time and reliability risks for the sponsor. This gives Medpace some protection on studies already underway, though sponsors can still move work to other CROs or internal teams.
Read the full moat analysis
Revenue & Expenses Breakdown
Medpace Holdings Inc
Earnings Waterfall
Medpace Holdings Inc
The intrinsic value for Medpace Holdings Inc (MEDP) under the Base Case is hidden USD.
Compared with the current market price of 654.19 USD, the stock appears hidden.
